The added strength of the new dressing makes it ideal for use in packing a wide variety of cavity wounds like post-surgical wounds, excised abscesses, pilonidal cysts, and stage III and stage IV pressure ulcers which have tunneling and undermining. AQUACEL Ag dressing also provides the broad-spectrum antimicrobial properties of ionic silver that kills a broad range of pathogens in the dressing, including vancomycin-resistant enterococci (VRE) and methicillin-resistant Staphylococcus aureus (MRSA) as demonstrated in vitro. A comparative in vitro testing of existing products showed new dressing has greater wet tensile strength, the measure of force necessary to break the dressing when wet than major competitors tested.

Dot Weir, welcomed the launch of the new AQUACEL Ag ribbon dressing in the US, The new dressing provides the continued performance of excellent absorption of the wound exudate we have come to expect from Hydrofiber Technology, with the added bonus of noticeable ease of removal and remarkable strength, providing pain reduction for the patient and confidence for the clinician.

The performance of AQUACEL Ag dressings is driven by Hydrofiber Technology. The dressings gel on contact with wound fluid to provide a moist wound healing environment, help protect the periwound skin, help manage exudate and reduce pain in situ and on removal. AQUACEL Ag dressing with the inclusion of ionic silver provides on demand antimicrobial activity, as demonstrated in vitro, responding to increased bacteria with increased silver ion availability. The new dressing starts killing a broad spectrum of pathogens, including MRSA, within 30 minutes of application. It can provide sustained antimicrobial activity for up to 14 days.

AQUACEL and AQUACEL Ag Dressings have been studied in many randomized clinical trials across a variety of acute and chronic wounds, including pressure ulcers, diabetic foot ulcers, leg ulcers, partial thickness (second degree) burns and surgical incisions.